Memantine in the Treatment of Executive Function Deficits in Adults With ADHD: A Pilot-Randomized Double-Blind Controlled Clinical Trial
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Objective: To evaluate the efficacy and safety of memantine hydrochloride as an adjunct to stimulant pharmacotherapy for treating executive function deficits (EFDs) in adults with ADHD. Method: This was a 12-week, double-blind, placebo-controlled, randomized clinical trial of memantine added to open-label treatment with stimulant medication. Because of the small sample size, we considered a standardized mean difference (equivalent to effect size) of ≥0.5 and odds ratios ≥2 as indicators of trend improvements. Results: Twelve participants received memantine and 14 received a placebo. Trend improvements favoring memantine were observed on Behavior Rating Inventory of Executive Functions–Adult Inhibition and Self-Monitor subscales when compared with Placebo. No significant changes were noted on the Cambridge Neuropsychological Test Automated Battery. Conclusion: Among adults with ADHD and EFDs, adjunct treatment with memantine to osmotic release oral system-methylphenidate (OROS-MPH) was associated with improvements in selective areas of executive functioning, supporting the need for further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · cited 2×
“ADHD is a chronic, persistent neurobiological disorder with childhood onset that is estimated to affect up to 5% of adults worldwide (Faraone, Sergeant, Gillberg, & Biederman, 2003; Kessler et al., 2006).”
BackgroundSelf-citationValidity of pilot Adult ADHD Self-Report Scale (ASRS) to rate adult ADHD symptoms
Adler, L. A., Spencer, T., Faraone, S. V., Kessler, R. C., Howes, M. J., Biederman, J., & Secnik, K. (2006) · Annals of Clinical Psychiatry · doi:10.1080/10401230600801077 · Cited by 677 · cited 2×
“Severity of ADHD symptoms was assessed with the AISRS, shown to be sensitive to drug effects in pediatric and adult populations (Adler et al., 2006), that assesses each of the 18 individual criteria symptoms of ADHD in DSM-IV on a severity grid (0 = not present; 3 = severe; overall minimum score =…”
MethodSelf-citationBiederman, J., Faraone, S. V., Spencer, T. J., Mick, E., Monuteaux, M. C., & Aleardi, M. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0403 · Cited by 565
Self-citationComparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis
Faraone, S. V., & Buitelaar, J. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0054-3 · Cited by 485 · cited 1×
“Whereas stimulants remain the mainstay of treatment for ADHD due to their large effect sizes (Alliance, 2008; Faraone, 2012; Faraone & Buitelaar, 2010; Faraone & Glatt, 2010; Kooij et al., 2004), their effects on EF deficits (EFDs) are more ambivalent and generally more modest.”
BackgroundSelf-citationBarkley, R. A., & Murphy, K. R. (2010) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acq014 · Cited by 468
Faraone, S. V., & Glatt, S. J. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04902pur · Cited by 387
Self-citationCoghill, D. R., Seth, S., Pedroso, S., Usala, T., Currie, J., & Gagliano, A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.005 · Cited by 271 · cited 1×
“For example, while Coghill et al. (2014) suggested that methylphenidate (MPH) had positive effects on several aspects of cognition, these authors did not separate executive from nonexecutive domains and many of their results remained equivocal.”
ResultBiederman, J., Petty, C., Fried, R., Fontanella, J., Doyle, A. E., Seidman, L. J., & Faraone, S. V. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.10.1730 · Cited by 213
Self-citationBiederman, J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.10.1730 · Cited by 183
Self-citationKOOIJ, J. J. S., BURGER, H., BOONSTRA, A. M., VAN DER LINDEN, P. D., KALMA, L. E., & BUITELAAR, J. K. (2004) · Psychological Medicine · doi:10.1017/s0033291703001776 · Cited by 163 · cited 1×
“Whereas stimulants remain the mainstay of treatment for ADHD due to their large effect sizes (Alliance, 2008; Faraone, 2012; Faraone & Buitelaar, 2010; Faraone & Glatt, 2010; Kooij et al., 2004), their effects on EF deficits (EFDs) are more ambivalent and generally more modest.”
BackgroundBrown, T. E., & Landgraf, J. M. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.09.2200 · Cited by 160 · cited 1×
“ADHD, adult, adult ADHD treatment, executive function deficits, memantine 40% of adults with ADHD were considered to have unresolved and clinically significant impairments in selfreported EFDs despite improvements in ADHD symptoms (Brown & Landgraf, 2010).”
BackgroundBiederman, J., Petty, C. R., Fried, R., Doyle, A. E., Spencer, T., Seidman, L. J., Gross, L., Poetzl, K., & Faraone, S. V. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01008.x · Cited by 159
Self-citationFaraone, S. V., Biederman, J., Doyle, A., Murray, K., Petty, C., Adamson, J. J., & Seidman, L. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.060 · Cited by 138 · cited 1×
“Deficits in a group of high-order cognitive functions termed executive functions (EFs) are a well-documented source of morbidity and disability in adults with ADHD (Barkley & Murphy, 2010; Biederman, Petty, et al., 2006; Biederman, Petty, Fried, Doyle, et al., 2007; Faraone et al., 2006).”
BackgroundSelf-citationBiederman, J., Petty, C. R., Fried, R., Black, S., Faneuil, A., Doyle, A. E., Seidman, L. J., & Faraone, S. V. (2008) · Journal of Attention Disorders · doi:10.1177/1087054707305111 · Cited by 123
Self-citationBiederman, J., Seidman, L. J., Petty, C. R., Fried, R., Doyle, A. E., Cohen, D. R., Kenealy, D. C., & Faraone, S. V. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0715 · Cited by 79
Self-citationBiederman, J., Mick, E., Fried, R., Wilner, N., Spencer, T. J., & Faraone, S. V. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.11.005 · Cited by 67 · cited 1×
“Similarly, a large randomized placebo-controlled clinical trial of OROS-MPH in adults with ADHD found that ADHD participants continued to have a large burden of impairing self-reported EFDs, despite robust improvements in ADHD symptoms (Biederman et al., 2011).”
BackgroundSelf-citationAnterior Cingulate Volumetric Alterations in Treatment-Naïve Adults With ADHD: A Pilot Study
Makris, N., Seidman, L. J., Valera, E. M., Biederman, J., Monuteaux, M. C., Kennedy, D. N., Caviness, V. S., Bush, G., Crum, K., Brown, A. B., et al. (2010) · Journal of Attention Disorders · doi:10.1177/1087054709351671 · Cited by 60
Self-citationSurman, C. B. H., Biederman, J., Spencer, T., Miller, C. A., Petty, C. R., & Faraone, S. V. (2015) · Journal of Attention Disorders · doi:10.1177/1087054713476548 · Cited by 35
Self-citation
Research works printed but not linked: 33
- American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders
- 10.1097/01.nmd.0000243968.06789.73 · DOI · Paper page
- 10.1002/(SICI)1098-2396(199806)29:2<142::AID-SYN5>3.0.CO;2-7 · DOI · Paper page
- Cambridge Cognition Limited, 2004, CANTABeclipse Test administration guide
- 10.1016/j.bandc.2006.11.002 · DOI
- 10.1016/j.schres.2007.07.034 · DOI
- Delis D., 2001, Delis-Kaplan executive function system (D-KEFS)
- Endicott J., 1997, Psychopharmacology Bulletin, 33, 13
- Endicott J., 1993, Psychopharmacology Bulletin, 29, 321
- 10.1177/1087054710379738 · DOI · Paper page
- Faraone S. V., 2003, World Psychiatry, 2, 104
- 10.1080/10550490601082767 · DOI · Paper page
- 10.1016/j.psychres.2010.12.030 · DOI
- 10.1002/gps.1341 · DOI · Paper page
- 10.1017/S0033291799008338 · DOI · Paper page
- 10.1016/j.jad.2011.09.040 · DOI
- 10.1002/gps.2226 · DOI · Paper page
- National Institute of Mental Health, 1985, Psychopharmacology Bulletin, 21, 839
- 10.1007/s00213-004-1833-7 · DOI
- Roth R., 2005, BRIEF-A Behavior Rating Inventory of Executive Function-Adult version, publication manual
- 10.1016/S0893-133X(97)00092-4 · DOI · Paper page
- 10.3109/15622975.2011.623716 · DOI
- 10.1097/00004583-199507000-00012 · DOI · Paper page
- Torgesen J., 1999, Test of word reading efficiency
- 10.1046/j.1440-1614.2003.01238.x · DOI · Paper page
- 10.1002/hbm.20789 · DOI
- 10.1016/j.neulet.2009.03.043 · DOI
- 10.1093/cercor/bhp145 · DOI · Paper page
- Wechsler D., 2008, Wechsler Adult Intelligence Scale - Fourth edition (WAIS-IV)
- Wechsler D., 2011, Wechsler Abbreviated Scale of Intelligence - Second edition (WASI-II)
- Weissman M. M., 1999, Social Adjustment Scale-self Report (SAS-SR): User’s manual
- 10.1097/00008877-200609000-00007 · DOI · Paper page
- Wilkinson G. S., 2006, Wide Range Achievement Test 4 Professional manual
Cited by
The Relationship Between Executive Function Deficits and DSM -5-Defined ADHD Symptoms
Silverstein, M. J., Faraone, S. V., Leon, T. L., Biederman, J., Spencer, T. J., & Adler, L. A. (2020) · Journal of Attention Disorders · doi:10.1177/1087054718804347 · Cited by 143
Self-citationAlcohol use disorders and ADHD.
Luderer, M., Ramos Quiroga, J. A., Faraone, S. V., Zhang-James, Y., & Reif, A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.010 · Cited by 102
Self-citationAgmatine rescues autistic behaviors in the valproic acid-induced animal model of autism
Kim, J.-W., Seung, H., Kim, K. C., Gonzales, E. L. T., Oh, H. A., Yang, S. M., Ko, M. J., Han, S.-H., Banerjee, S., & Shin, C. Y. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.014 · Cited by 102
Nonstimulant Treatments for ADHD
Newcorn, J. H., Krone, B., & Dittmann, R. W. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.03.005 · Cited by 29
Gutman, S. A., Balasubramanian, S., Herzog, M., Kim, E., Swirnow, H., Retig, Y., & Wolff, S. (2020) · American Journal of Occupational Therapy · doi:10.5014/ajot.2020.033316 · Cited by 19
Metadata
- Authors
- Biederman, J., Fried, R., Tarko, L., Surman, C., Spencer, T., Pope, A., Grossman, R., McDermott, K., Woodworth, K. Y., & Faraone, S. V.
- Venue
- Journal of Attention Disorders
- Publisher
- SAGE Publications
- Published
- 2016-07-28
- Volume
- 21
- Issue
- 4
- Pages
- 343-352
- ISSN
- 1087-0547 (ISSN-L)
- 1557-1246
- OpenAlex
- W1992634156
- Cited by
- 50
- References
- 18
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.